ResearcherUniversity of CologneNo recent work listed

Sebastian Yves Friedrich Michels

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3164-870X; OpenAlex author ID A5037915780. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper

Papers 1

Durable Response With Sequential Tyrosine Kinase Inhibitor Treatment in a Patient With ROS1 Fusion-Positive Pancreatic Adenocarcinoma: A Case Report. Last author DOI 10.1200/po.22.00467 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dirk‐Thomas Waldschmidt · 1 shared paper, 2023 · strength 0.14
- Paper Durable Response With Sequential Tyrosine Kinase Inhibitor Treatment in a Patient With ROS1 Fusion-Positive Pancreatic … DOI 10.1200/po.22.00467 ↗
Theresa Reutter · 1 shared paper, 2023 · strength 0.14
- Paper Durable Response With Sequential Tyrosine Kinase Inhibitor Treatment in a Patient With ROS1 Fusion-Positive Pancreatic … DOI 10.1200/po.22.00467 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.